Topical trichloroacetic acid versus electrocautery for treatment of anal intraepithelial neoplasia in people living with HIV: a multicentre, randomised, non-inferiority trial (TECAIN-study) - Report - MDSpire
Advertisement
Topical trichloroacetic acid versus electrocautery for treatment of anal intraepithelial neoplasia in people living with HIV: a multicentre, randomised, non-inferiority trial (TECAIN-study)
Clinical Report: Comparative Efficacy of TCA and Electrocautery for AIN
Overview
The TECAIN study evaluates the efficacy and safety of topical trichloroacetic acid (TCA) versus electrocautery (ECA) for treating anal intraepithelial neoplasia (AIN) in HIV-positive individuals.
Background
Anal squamous cell carcinoma is linked to high-risk HPV infections and has a significantly higher incidence in people living with HIV (PLWH). Early treatment of high-grade anal intraepithelial lesions (HSIL) is crucial to reduce the risk of progression to anal cancer. Current treatment options, including electrocautery, have limitations such as high recurrence rates and the need for local anesthesia.
Data Highlights
No numerical data provided in the source material.
Key Findings
The TECAIN study is a multicenter, randomized non-inferiority trial comparing TCA and ECA for AIN treatment.
Topical TCA is proposed as a less complex and well-tolerated alternative to ECA.
High recurrence rates of AIN after treatment remain a significant concern in PLWH.
Current treatment modalities for AIN have rarely been evaluated in prospective randomized trials.
Electrocautery is the most frequently used approach but requires special equipment and trained personnel.
Clinical Implications
Understanding the comparative efficacy of these treatments is essential.
Conclusion
The TECAIN study aims to provide insights into the treatment of AIN in HIV-positive individuals.
by Stefan Esser, Alexander Kreuter, Anja Potthoff, Robert Jablonka, Mark Oette, Martin F. Sprinzl, Daniel Exner, Konstantinos Bilbilis, Hildegard Lax, Eva-Maria Huessler, Steffi Silling, Ulrike Wieland